• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIABETES CARE, INC. ACCU-CHEK INSIGHT FLEX; SUBCUTANEOUS INFUSION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIABETES CARE, INC. ACCU-CHEK INSIGHT FLEX; SUBCUTANEOUS INFUSION SET Back to Search Results
Lot Number 1306895
Device Problem Fluid/Blood Leak (1250)
Patient Problem Injection Site Reaction (4562)
Event Date 04/06/2021
Event Type  malfunction  
Manufacturer Narrative
The event occurred outside of the united states.While this product is not sold in the united states, it is like or similar to a product marketed in the united states.
 
Event Description
It was reported that the infusion set was leaking at the headset.The customer reported that the adhesive plaster was wet and that the skin under the infusion set was red and swollen.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCU-CHEK INSIGHT FLEX
Type of Device
SUBCUTANEOUS INFUSION SET
Manufacturer (Section D)
ROCHE DIABETES CARE, INC.
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11632512
MDR Text Key244365916
Report Number3011393376-2021-01141
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/08/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/16/2022
Device Lot Number1306895
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/21/2021
Date Manufacturer Received05/21/2021
Patient Sequence Number1
Treatment
NOVORAPID INSULIN; NOVORAPID INSULIN
Patient Age22 YR
Patient Weight96
-
-